PRINCETON, N.J., May 24 /PRNewswire-FirstCall/ -- Pharmasset, Inc. announced today that its management will be presenting at the Bank of America 2007 Healthcare Conference being held from May 30 - June 1, 2007 in Las Vegas, Nevada. Schaefer Price, Pharmasset’s President & Chief Executive Officer, will provide an overview of the company on Thursday, May 31, 2007 at 12:40 p.m. Pacific Standard Time.
To access the live webcast of the presentation via the Internet, log on to the “Events & Presentations” section of Pharmasset’s corporate website at http://www.pharmasset.com. Please connect to the company’s website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary to listen to the webcast. The archived replay of the webcast will be available on the Pharmasset website for two weeks following the conference. The company presentation will be available for download in PDF format in the “Investor Presentations” section of the Investor Center of the Pharmasset website immediately following the presentation.
About Pharmasset
Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset’s primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Pharmasset is currently developing three product candidates: Clevudine for the treatment of HBV, which is entering US and EU Phase 3 registration clinical trials and is already approved for HBV in Korea and marketed by Bukwang Pharmaceuticals under the brand name Levovir; R7128, an oral treatment for HCV, in a Phase 1 clinical trial through a strategic collaboration with Hoffmann-LaRoche; and Racivir for the treatment of HIV in combination with other approved HIV drugs, in a Phase 2 clinical trial.
VRUS-G Contact: Alan Roemer, Vice President Investor Relations & Corporate Communications alan.roemer@pharmasset.com Office: (609) 613-4125
Pharmasset, Inc.
CONTACT: Alan Roemer, Vice President, Investor Relations & CorporateCommunications of Pharmasset, +1-609-613-4125, alan.roemer@pharmasset.com
Web site: http://www.pharmasset.com/
